Oncology Associates PC
Omaha, Nebraska, United States
Cancer treatment center in Omaha, Nebraska
515 N 162nd Ave, Omaha, NE 68118
About Oncology Associates PC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
15
NRG Oncology
3
Alliance for Clinical Trials in Oncology
2
ECOG-ACRIN Cancer Research Group
2
SWOG Cancer Research Network
1
Clinical Trials at Oncology Associates PC
During the past decade, Oncology Associates PC conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
2017-01-13
2023-10-31
Active, not recruiting
818
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
2018-04-05
2025-06-30
Recruiting
20
Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
2019-03-29
2025-01-31
Active, not recruiting
62
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
2018-10-24
2028-01-01
Active, not recruiting
84
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Oncology Associates PC" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "NRG Oncology" with 3 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "SWOG Cancer Research Network"
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Associates PC"
#1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Oncology Associates PC
According to Clinical.Site data, the most researched conditions in "Oncology Associates PC" are
"Recurrent Lung Non-Small Cell Carcinoma" (3 trials), "Recurrent Uterine Corpus Cancer" (3 trials), "Stage IIIB Lung Cancer AJCC v8" (3 trials), "Stage IV Lung Cancer AJCC v8" (3 trials) and "Endometrioid Adenocarcinoma" (2 trials). Many other conditions were trialed in "Oncology Associates PC" in a lesser frequency.
Clinical Trials Intervention Types at Oncology Associates PC
Most popular intervention types in "Oncology Associates PC" are "Drug" (17 trials), "Procedure" (14 trials), "Biological" (12 trials), "Other" (11 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Biospecimen Collection" (11 trials), "Computed Tomography" (10 trials), "Magnetic Resonance Imaging" (7 trials), "Pembrolizumab" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Oncology Associates PC
The vast majority of trials in "Oncology Associates PC" are
18 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Oncology Associates PC
Currently, there are NaN active trials in "Oncology Associates PC".
undefined are not yet recruiting,
15 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Oncology Associates PC,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Associates PC, 0 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".